EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ex vivo expansion reshapes invariant natural killer T-cell state, function, and therapeutic fitness

Naeimeh Tavakolinia

Clinical Immunology · 2026-12 · 288 · 110783

DOI: 10.1016/j.clim.2026.110783 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Immunology, 2026-12. Verfasst von Naeimeh Tavakolinia. Beteiligte Einrichtung: Murdoch Children's Research Institute, Melbourne, Australia; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Imm…. Die Arbeit nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invariant natural killer T cells are uniquely positioned at the interface of innate and adaptive immunity, combining CD1d-restricted antigen recognition with rapid, diverse cytokine responses and relatively low HLA-driven alloreactivity. These properties make them attractive candidates for adoptive cellular immunotherapy, yet clinical translation has remained limited by inconsistent potency and persistence. This review considers ex vivo expansion as a determinant of product state rather than a passive scale-up step. Cytokine support, antigen and co-stimulatory signals, restimulation schedule, and culture duration can alter iNKT cell subset composition, survival, phenotype, and effector function, thereby influencing therapeutic fitness. We further discuss how human iNKT cell developmental biology and subset heterogeneity provide a framework for interpreting donor variability and culture-induced drift. We also compare peripheral-blood, hematopoietic stem/progenitor cell (HSPC)-derived, and induced pluripotent stem cell (iPSC)-derived manufacturing platforms and propose critical quality attributes (CQAs) for identity, potency, persistence, survival, and manufacturing safety. Progress will require manufacturing strategies that achieve clinically relevant expansion while preserving a defined and functionally validated cell state.

Schlagwörter

Stichwörter der Autor:innen

CAR-iNKTEx vivo expansionOff-the-shelf immunotherapyiNKT cellsΑ-Galactosylceramide

Autor:innen und Institutionen

  • Murdoch Children's Research Institute, Melbourne, Australia; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia. Electronic addre…

Zitieren

APA

Tavakolinia, N. (2026). Ex vivo expansion reshapes invariant natural killer T-cell state, function, and therapeutic fitness. Clinical Immunology, 288, 110783. https://doi.org/10.1016/j.clim.2026.110783

Vancouver

Tavakolinia N. Ex vivo expansion reshapes invariant natural killer T-cell state, function, and therapeutic fitness. Clinical Immunology. 2026;288:110783. doi:10.1016/j.clim.2026.110783

BibTeX
@article{Tavakolinia2026,
  author = {Tavakolinia, Naeimeh},
  title = {Ex vivo expansion reshapes invariant natural killer T-cell state, function, and therapeutic fitness},
  journal = {Clinical Immunology},
  year = {2026},
  volume = {288},
  pages = {110783},
  doi = {10.1016/j.clim.2026.110783}
}
Kostenlos starten →